Stories

Rebecca Stone

Staff writer covering money, funding and market shifts around global pharmaceutical industry at PharmInsider.

10 articles

U/AUTHOR

Stories

10 filings logged

Unit log

  1. K-3717

    FDA Moves to Withdraw Approval of FloLipid Liquid Simvastatin

  2. C-7994

    FDA grants GSK accelerated approval for ALK inhibitor Nelkarmi

  3. K-8685

    FDA Clears Cosentyx for Polymyalgia Rheumatica, 11th US Indication

  4. E-9238

    Flagship Puts £100M Into First Non-U.S. Company Creation Lab in London

  5. K-5091

    ImmunoBrain's Anti-PD-L1 Antibody Cuts Alzheimer's Damage Biomarkers in Phase Ib

  6. T-8005

    Pfizer secures up to $1.5B for berobenatide trials

  7. E-5590

    Trump withdraws Overton, widening FDA leadership gap for sponsors

  8. K-6477

    EU regulators weigh streamlining combination product reviews

  9. K-1065

    FDA rejects China-developed Ivonescimab on overall-survival grounds